Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal

Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal

Purpose: Chemoradiation therapy (CRT) is the standard treatment for squamous cell carcinoma of the anus (SCCA). This study aimed to investigate the relationship between vaginal dosimetry and long-term patient-reported dyspareunia after treatment. We further aimed to use the anterior vaginal wall (AV...

Full description

Bibliographic Details
Main Authors: Michael K. Rooney, MD, Joshua S. Niedzielski, PhD, Ramon M. Salazar, PhD, Angelica Arzola, PA-C, Prajnan Das, MD, MS, MPH, Eugene J. Koay, MD, PhD, Albert Koong, MD, PhD, Ethan B. Ludmir, MD, Bruce D. Minsky, MD, Sonal Noticewala, MD, Grace L. Smith, MD, PhD, MPH, Cullen Taniguchi, MD, PhD, Emma B. Holliday, MD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109424000125

Internet

http://www.sciencedirect.com/science/article/pii/S2452109424000125

Similar Items